Published in Vaccine Weekly, September 19th, 2001
Pivotal Research Centers are enrolling patients for the 15-month experiment. Scott Gardner, executive director of the Arizona chapter of the Alzheimer's Association, said two recent studies have shown that the vaccine appears to work in mice. Gardner said the vaccine trial in humans now gives hope to victims of the disease and their families.
"It's extremely, extremely promising and, yes, it's an attainable goal,'' he said.
At least 25 people with mild-to-moderate Alzheimer disease will be chosen for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.